Human Physiology I · Synaptic Physiology

Major Neurotransmitter Systems

7 min read
Want it in plain words first? Jump to Eli explains — the same idea, no jargon.
On this page 7 sections
  1. In 30 seconds
  2. Why this matters
  3. The college version
  4. Eli explains
  5. Worked example
  6. Key takeaway
  7. Study tools

In 30 seconds

are chemical messengers grouped into small molecules (, the biogenic amines , , , , , and the amino acids , , ), , and . Whether a transmitter excites or inhibits depends on the receptor it binds, not on its identity alone: glutamate is the main excitatory transmitter, while GABA and glycine are the main inhibitory ones. Each transmitter follows a common lifecycle of synthesis, storage, release, reuptake, and degradation, with receptor-dependent effects shaped by receptor subtypes such as nicotinic versus muscarinic acetylcholine receptors.

Why this matters

The transmitter lifecycle is the foundation of neuropharmacology. Reuptake inhibitors raise synaptic serotonin (and/or norepinephrine) and are used for mood disorders; acetylcholinesterase inhibitors raise acetylcholine at the neuromuscular junction; and dopamine precursors or receptor modulators are used when dopamine neurons are lost in movement disorders. Receptor selectivity explains side effects: drugs that block muscarinic receptors, for example, produce dry mouth and blurred vision by blocking ACh throughout the body. In the laboratory, transmitters are identified by immunostaining their synthetic enzymes and by measuring release with microdialysis or electrochemical sensors. These notes describe mechanisms for education only; specific medications, indications, and dosing vary by jurisdiction and require clinical supervision.

The college version

1. What Makes a Chemical a Neurotransmitter, and Its Lifecycle

A substance is classically considered a neurotransmitter if it is synthesized and stored in the presynaptic neuron, released in response to stimulation, acts on specific postsynaptic receptors, and is removed by a specific mechanism. Every transmitter follows a shared lifecycle: synthesis (from precursors by enzymes), storage in vesicles, release by calcium-dependent exocytosis (Topic 12), action on receptors, and termination by reuptake and/or degradation. This lifecycle is the target of many drugs.

2. Acetylcholine and the Biogenic Amines

Acetylcholine (ACh) is synthesized from choline and acetyl-CoA, released at the neuromuscular junction and throughout the brain and autonomic system, and inactivated by acetylcholinesterase. Its two receptor families show the receptor-dependence rule perfectly: nicotinic receptors are ionotropic (fast, excitatory), while muscarinic receptors are metabotropic GPCRs (slower, excitatory or inhibitory depending on subtype). The biogenic amines share a common synthetic root in amino acids: dopamine, norepinephrine, and epinephrine are catecholamines (derived from tyrosine) involved in reward, movement, arousal, and the fight-or-flight response; serotonin (5-HT, from tryptophan) regulates mood, sleep, and appetite; histamine (from histidine) promotes wakefulness and is central to allergy and gastric acid secretion. Amines are typically cleared by reuptake transporters, and their degradation by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) is a major drug target.

3. Amino Acids, Neuropeptides, and Purines

The amino acids are the workhorses of fast synaptic signaling. Glutamate is the principal excitatory neurotransmitter (acting on AMPA, NMDA, and kainate ionotropic receptors plus metabotropic glutamate receptors). GABA is the principal inhibitory transmitter in the brain (GABA-A ionotropic, GABA-B metabotropic), and glycine is the principal inhibitory transmitter in the spinal cord and brainstem. Neuropeptides (e.g., substance P, endorphins, oxytocin) are larger, synthesized in the cell body, stored in dense-core vesicles, and released for slower, longer-lasting modulation. Purines such as ATP and adenosine are co-released with other transmitters and signal through purinergic receptors; adenosine in particular is an inhibitory neuromodulator. Across all systems, excitatory vs inhibitory effects are receptor-dependent effects — a transmitter is excitatory, inhibitory, or modulatory only through the receptor it activates.

How it works

  1. A neuron synthesizes its transmitter from precursors via specific enzymes.
  2. Transmitter is stored in vesicles (or dense-core vesicles for peptides).
  3. An action potential triggers calcium-dependent release into the cleft.
  4. Transmitter binds receptors; the receptor subtype determines the effect (excitatory, inhibitory, or modulatory).
  5. Reuptake transporters and degradative enzymes terminate the signal.
  6. Peptides and purines provide slower, longer-lasting modulation alongside classical transmitters.

Common confusions

Do not confuseWithDifference
Nicotinic receptorMuscarinic receptorIonotropic (fast) vs. metabotropic (GPCR) ACh receptor
GlutamateGABAPrincipal excitatory vs. principal inhibitory transmitter
GlycineGABASpinal/brainstem inhibition vs. brain-wide inhibition
NeuropeptideSmall-molecule transmitterMade in cell body, slow vs. made in terminal, fast
EpinephrineNorepinephrineA circulating hormone vs. primarily a synaptic transmitter

Memory aids

"DANSEH" for the amines — Dopamine, Acetylcholine, Norepinephrine/Epinephrine, Serotonin, Histamine — and "Glu excites; GABA and Glycine guard." For receptors: "Nicotinic = Nimble-fast (ionotropic); Muscarinic = Mushroom-slow (metabotropic)."

Quick review

Topic Recap

Neurotransmitters span small molecules (acetylcholine, the amines dopamine/norepinephrine/epinephrine/serotonin/histamine, and the amino acids glutamate/GABA/glycine), neuropeptides, and purines. Each follows the lifecycle of synthesis, storage, release, reuptake, and degradation. Crucially, whether a transmitter excites or inhibits depends on its receptor — nicotinic versus muscarinic ACh receptors illustrate this — and glutamate, GABA, and glycine define the basic excitatory and inhibitory framework of the nervous system.

Knowledge Check

  1. What determines whether a neurotransmitter is excitatory or inhibitory?
  2. Identify the principal excitatory and the two principal inhibitory neurotransmitters, and where each inhibits.
  3. Contrast nicotinic and muscarinic acetylcholine receptors.
  4. List the five stages of the neurotransmitter lifecycle.
  5. Name the three catecholamines and the amino acid they are all derived from.

Answers and Rationales

  1. The receptor subtype (and its coupled channels/effectors), not the transmitter molecule. The same transmitter can excite at one receptor and inhibit at another.
  2. Glutamate is the main excitatory transmitter; GABA inhibits in the brain and glycine in the spinal cord/brainstem.
  3. Nicotinic receptors are ionotropic (fast, excitatory); muscarinic receptors are metabotropic GPCRs (slower, subtype-dependent).
  4. Synthesis, storage, release, reuptake, and degradation.
  5. Dopamine, norepinephrine, and epinephrine — all derived from the amino acid tyrosine.
Eli, the EliExplains learning guide

Eli explains

The same idea, in plain words

Explain it like I’m 10

Think of neurotransmitters as a fleet of delivery trucks. Each truck carries a different package (molecule) and has its own route (neurons that use it), but what matters for the customer is which dock it unloads at — the receptor. The same truck can deliver an "excite" message at one dock and a "calm down" message at another. Glutamate trucks mostly deliver "excite," while GABA and glycine trucks mostly deliver "calm down." After unloading, the truck is either sent back to the depot (reuptake), disassembled (degradation), or drives away (diffusion).

Where it stops being exact: Neurotransmitters are not literally vehicles, and a single transmitter does not "choose" its effect — the receptor subtype and the ion channels it couples to dictate the response. Also, peptides are made in the cell body and shipped down the axon, unlike small-molecule transmitters made right at the terminal.

Simple Example

Acetylcholine excites skeletal muscle through nicotinic receptors (ionotropic, fast), but it slows the heart through muscarinic receptors (metabotropic, G-protein-coupled). Same transmitter, opposite effects — because the receptor, not the molecule, decides the outcome.

Worked example

  1. Synthesis. Small-molecule transmitters are made in the terminal by specific enzymes (e.g., choline acetyltransferase for ACh, tyrosine hydroxylase for catecholamines); peptides are made in the cell body and transported down the axon.
  2. Storage. Transmitter is concentrated into synaptic vesicles by vesicular transporters (or dense-core vesicles for peptides).
  3. Release. Calcium-dependent exocytosis dumps transmitter into the cleft (Topic 12).
  4. Receptor binding — direction of effect. Binding an ionotropic receptor directly opens channels (fast EPSP or IPSP); binding a metabotropic GPCR changes second messengers (slower, modulatory). The receptor, not the molecule, sets excitatory versus inhibitory sign.
  5. Reuptake and degradation. Transporters (e.g., serotonin transporter SERT, dopamine transporter DAT, norepinephrine transporter NET) pump transmitter back; enzymes (acetylcholinesterase, MAO, COMT) break it down. Peptides are removed mainly by diffusion and peptidases.
  6. Why physiology changes. Blocking reuptake (many antidepressants) or degradation (MAO inhibitors) raises cleft transmitter and prolongs its action, while blocking receptors changes downstream signaling — the mechanistic basis of most neuropharmacology.

Key takeaways

  • High yield: Excitatory vs inhibitory is a property of the receptor, not the transmitter molecule.
  • High yield: Glutamate = main excitatory transmitter; GABA (brain) and glycine (spinal cord) = main inhibitory transmitters.
  • High yield: Nicotinic receptors are ionotropic (fast); muscarinic receptors are metabotropic (GPCR).
  • Dopamine, norepinephrine, and epinephrine are catecholamines made from tyrosine; serotonin comes from tryptophan; histamine from histidine.
  • Amines are cleared mainly by reuptake (DAT, NET, SERT) and degraded by MAO/COMT; ACh is degraded by acetylcholinesterase.
  • Neuropeptides are made in the cell body and act slowly; ATP/adenosine (purines) are co-transmitters, with adenosine typically inhibitory.
  • Every transmitter follows the lifecycle: synthesis → storage → release → reuptake/degradation.

Keep learning

Ready to build on this? Continue to the next lesson.

Study tools & related lessonsYou’ll learn to · Key vocabulary · Related

You’ll learn to

  • Define the classical criteria for a neurotransmitter and outline the general lifecycle of synthesis, storage, release, reuptake, and degradation.
  • Describe acetylcholine and its nicotinic versus muscarinic receptors.
  • Identify the key biogenic amines — dopamine, norepinephrine, epinephrine, serotonin, and histamine — and their general roles.
  • Explain glutamate, GABA, and glycine as the principal excitatory and inhibitory amino acids, and contrast neuropeptides and purines with classical transmitters, emphasizing receptor-dependent (excitatory vs inhibitory) effects.

Key vocabulary

Neurotransmitters
Chemical messengers released at synapses
Acetylcholine
ACh, the transmitter at neuromuscular and many autonomic/central synapses
Nicotinic receptors
Ionotropic ACh receptors
Muscarinic receptors
Metabotropic (GPCR) ACh receptors
Dopamine
Catecholamine for reward, movement, motivation
Norepinephrine
Catecholamine for arousal and sympathetic signaling
Epinephrine
Catecholamine hormone/transmitter (adrenaline)
Serotonin
5-HT amine regulating mood, sleep, appetite
Histamine
Amine promoting wakefulness; allergy/gastric roles
Glutamate
Principal excitatory amino acid transmitter
GABA
Principal inhibitory transmitter of the brain
Glycine
Principal inhibitory transmitter of spinal cord/brainstem
Neuropeptides
Large peptide modulators (substance P, opioids)
Purines
ATP, adenosine acting as transmitters/modulators
Excitatory vs inhibitory effects
Whether a signal promotes or suppresses firing
Receptor-dependent effects
Outcome depends on receptor subtype activated

Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.